Page last updated: 2024-10-22

alendronate and Aggressive Systemic Mastocytosis

alendronate has been researched along with Aggressive Systemic Mastocytosis in 2 studies

alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.

Aggressive Systemic Mastocytosis: A form of systemic mastocytosis in which patients have impaired organ functions due to multifocal infiltrates of pathological MAST CELLS in bone marrow, liver, spleen, gastrointestinal tract, or skeletal system. The cytomorphology shows a low to high grade.

Research Excerpts

ExcerptRelevanceReference
"Systemic mastocytosis is a rare but well-recognised cause of secondary osteoporosis, accounting for about 1."1.35Systemic mastocytosis presenting as osteoporosis--a case report. ( Dhillon, V; Mathew, R; Shepherd, P, 2009)
"Systemic mastocytosis is a rare and occasionally aggressive condition that raises major diagnostic challenges."1.32Aggressive systemic mastocytosis. ( Bertin, P; Inaoui, R; Jaccard, A; Petit, B; Trèves, R, 2003)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mathew, R1
Dhillon, V1
Shepherd, P1
Inaoui, R1
Petit, B1
Jaccard, A1
Bertin, P1
Trèves, R1

Other Studies

2 other studies available for alendronate and Aggressive Systemic Mastocytosis

ArticleYear
Systemic mastocytosis presenting as osteoporosis--a case report.
    Clinical rheumatology, 2009, Volume: 28, Issue:7

    Topics: Alendronate; Bone Density Conservation Agents; Diagnosis, Differential; Exanthema; Humans; Lumbar Ve

2009
Aggressive systemic mastocytosis.
    Joint bone spine, 2003, Volume: 70, Issue:1

    Topics: Aged; Alendronate; Bone Marrow Cells; Fatal Outcome; Female; Humans; Interferon-alpha; Leukemia, Mye

2003